Weitz & Luxenberg attorneys from New York and New Jersey were recently recognized as The Best Lawyers in America by Best Lawyers for the year 2020 and by Super…
Read MoreWeitz & Luxenberg is currently accepting clients who received a first generation Smith & Nephew Journey BCS knee and subsequently needed to undergo a revision, or replacement, surgery or have been advised by their doctor they need to undergo a revision surgery due to femoral component loosening. We invite you to contact us for more information about your legal options.
If you have undergone a knee replacement surgery, are having problems, and are not sure whether you received a first generation Smith & Nephew Journey BCS knee, we encourage you to ask your doctor which knee replacement model you received. Depending on your specific implant, you may be able to seek compensation.
Revision surgeries are costly. You may also need to undergo follow-up treatment and physical therapy.
You may not be able to earn a living if your knee complications keep you disabled at home. Your total medical costs could become exorbitant.
Smith & Nephew voluntarily recalled its first generation Journey BCS Knee System on June 13, 2018. The U.S. Food and Drug Administration later categorized this recall as Class 2. (1) (2)
For a free consultation and more information about your legal options, please contact us today.
Get a Free Case ReviewThe manufacturer indicated in its Urgent Field Safety Notice that this knee was failing as a higher rate than other primary total knee arthroplasty implants. It noted that data in two joint registries “indicate that the first generation JOURNEY BCS Knee System has a revision rate over 1.5 times the primary total knee arthroplasty device class average revision rates reported in those registries.” (3) (4) (5)
In its Urgent Field Safety Notice Smith & Nephew asked customers to inspect inventory and locate and quarantine affected, unused devices. (6) (7) (8)
In its Urgent Field Safety Notice, Smith & Nephew said the affected product was its first-generation Journey BCS, which was introduced to the market in 2005. The company phased this model out of production between 2013 and 2014. (9) (10)
Smith & Nephew said its “analysis of available post-market surveillance data suggests that patients that have been implanted with a first generation JOURNEY BCS Knee System may have a higher risk of requiring a revision earlier than they or their surgeon had expected.” (11) (12)
On July 23, 2018, the United Kingdom issued a medical device alert instructing against implanting Smith & Nephew’s first generation Journey BCS knee device and cautioned physicians to monitor patients regularly for up to 10 years for signs of device loosening. (13) (14)
In addition, the U.K.’s medical device alert notes the National Joint Registry of England, Wales, and Northern Ireland showed the revision rate for this knee device was more than double the average rate for primary total knee replacements. (15) (16)
According to authors of one study partially funded by Smith & Nephew, Smith & Nephew’s first generation Journey BCS had a significantly higher rate of revision than Smith & Nephew’s Journey II knee. The Journey I had a risk of revision over four times higher than the Journey II. (17) (18)
Weitz & Luxenberg has been litigating cases involving defective medical devices for decades. As a national firm, we are prepared to handle large-scale medical device litigation across the country.
Our attorneys make it their mission to help clients harmed by defective medical products any medical device corporations create and promote. They are specially trained to handle complex medical device lawsuits.
If you were implanted with a defective knee replacement, we may be able to seek appropriate compensation on your behalf. Over the years, we have secured millions of dollars on behalf of clients injured by faulty medical devices.
For more information, we encourage you to contact us at (800) 476-6070.